Answers are grounded in this paper and cite their sources.
Low amniotic fluid volume, or oligohydramnios, may be associated with obstetric complications and adverse neonatal outcomes, although the strength of these associations varies across clinical settings. This study aimed to determine the association between oligohydramnios and adverse perinatal outcomes among pregnant women in the third trimester. A prospective observational cohort study was conducted in the Department of Obstetrics and Gynecology, DHQ Teaching Hospital, Mirpur, Azad Jammu and Kashmir, Pakistan, from April to July 2026. Consecutive non-probability sampling was used to recruit 200 pregnant women, comprising an oligohydramnios group with an amniotic fluid index (AFI) <5 cm (n=100) and a normal-AFI group (n=100). Participants were followed until delivery, and maternal and neonatal outcomes were compared between the groups. Cesarean delivery (61.0% vs. 42.0%, p=0.008), intrapartum fetal distress (45.0% vs. 22.0%, p<0.001), low birth weight (34.0% vs. 18.0%, p=0.014), preterm delivery (28.0% vs. 12.0%, p=0.006), and a five-minute Apgar score <7 (38.0% vs. 20.0%, p=0.007) were more frequent in the oligohydramnios group according to the reported comparisons. Neonatal intensive care unit (NICU) admission and mean NICU length of stay were also higher. Perinatal mortality did not differ significantly in the reported analysis (6.0% vs. 1.0%, p=0.120). Third trimester oligohydramnios was associated with several adverse obstetric and neonatal outcomes in this cohort. These unadjusted findings support assessment alongside gestational age, maternal characteristics, and fetal status; they do not establish causality or an independent predictive effect.
No takes yet. Share an insight, caveat, or question.
Qurban et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: